Drug profile · INN
lutropin alfa
LUVERIS
lutropin alfa (LUVERIS) is a luteinizing hormone/choriogonadotropin receptor agonist. Associated with Merck KGaA, Darmstadt, Germany.
EMA: approved TGA: approved Genito-urinary system and sex hormones (G03) G03GA07
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — lutropin alfa
- Class
- Genito-urinary system and sex hormones (G03)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
lutropin alfa (LUVERIS) is a luteinizing hormone/choriogonadotropin receptor agonist. Associated with Merck KGaA, Darmstadt, Germany.
Key facts
INN lutropin alfa
Brand LUVERIS
Mechanism Luteinizing hormone/Choriogonadotropin receptor agonist
Target Lutropin-choriogonadotropic hormone receptor
Therapeutic class Genito-urinary system and sex hormones (G03)
ATC code G03GA07
Originator Merck KGaA, Darmstadt, Germany
Mechanism of action
Luteinizing hormone/Choriogonadotropin receptor agonist
Primary target: Lutropin-choriogonadotropic hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is lutropin alfa?
lutropin alfa (LUVERIS) is a luteinizing hormone/choriogonadotropin receptor agonist. Associated with Merck KGaA, Darmstadt, Germany.
What is the brand name for lutropin alfa?
LUVERIS is a marketed brand name for lutropin alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.